Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
Hannele Yki‐Järvinen
The Lancet Diabetes & Endocrinology (2014) Vol. 2, Iss. 11, pp. 901-910
Closed Access | Times Cited: 1130

Showing 1-25 of 1130 citing articles:

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Journal of Hepatology (2016) Vol. 64, Iss. 6, pp. 1388-1402
Open Access | Times Cited: 4257
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman, Brent A. Neuschwander‐Tetri, Mary E. Rinella, et al.
Nature Medicine (2018) Vol. 24, Iss. 7, pp. 908-922
Open Access | Times Cited: 3319
Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease
Alan Chait, Laura J. den Hartigh
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 1031
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
Thomas G. Cotter, Mary E. Rinella
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1851-1864
Closed Access | Times Cited: 995
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu, Stephen A. Harrison, Sven Francque, et al.
Gastroenterology (2016) Vol. 150, Iss. 5, pp. 1147-1159.e5
Open Access | Times Cited: 921
NAFLD and diabetes mellitus
Herbert Tilg, Alexander R. Moschen, Michael Roden
Nature Reviews Gastroenterology & Hepatology (2016) Vol. 14, Iss. 1, pp. 32-42
Closed Access | Times Cited: 846
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Judith Aron‐Wisnewsky, Chloé Vigliotti, Julia J. Witjes, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 5, pp. 279-297
Open Access | Times Cited: 774
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
Norbert Stefan, Hans‐Ulrich Häring, Kenneth Cusi
The Lancet Diabetes & Endocrinology (2018) Vol. 7, Iss. 4, pp. 313-324
Closed Access | Times Cited: 732
Nonalcoholic fatty liver disease
Elizabeth M. Brunt, Vincent Wai‐Sun Wong, Valério Nobili, et al.
Nature Reviews Disease Primers (2015) Vol. 1, Iss. 1
Closed Access | Times Cited: 713
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Na Xie, Lu Zhang, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 646
Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
Amedeo Lonardo, Stefano Ballestri, Giulio Marchesini, et al.
Digestive and Liver Disease (2014) Vol. 47, Iss. 3, pp. 181-190
Open Access | Times Cited: 630
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Amedeo Lonardo, Fabio Nascimbeni, Alessandro Mantovani, et al.
Journal of Hepatology (2017) Vol. 68, Iss. 2, pp. 335-352
Closed Access | Times Cited: 625
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Diabetologia (2016) Vol. 59, Iss. 6, pp. 1121-1140
Open Access | Times Cited: 583
The Natural Course of Non-Alcoholic Fatty Liver Disease
Luis Calzadilla Bertot, Leon A. Adams
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 5, pp. 774-774
Open Access | Times Cited: 565
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
Sven Francque, Pierre Bédossa, Vlad Ratziu, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 17, pp. 1547-1558
Open Access | Times Cited: 482
The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
Chiara Saponaro, Melania Gaggini, Fabrizia Carli, et al.
Nutrients (2015) Vol. 7, Iss. 11, pp. 9453-9474
Open Access | Times Cited: 452
EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease

Obesity Facts (2016) Vol. 9, Iss. 2, pp. 65-90
Open Access | Times Cited: 450
Non-alcoholic fatty liver disease, obesity and the metabolic syndrome
Peter Dietrich, Claus Hellerbrand
Best Practice & Research Clinical Gastroenterology (2014) Vol. 28, Iss. 4, pp. 637-653
Closed Access | Times Cited: 418
Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
Panu K. Luukkonen, You Zhou, Sanja Sädevirta, et al.
Journal of Hepatology (2016) Vol. 64, Iss. 5, pp. 1167-1175
Open Access | Times Cited: 401
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance
Melania Gaggini, Fabrizia Carli, Chiara Rosso, et al.
Hepatology (2017) Vol. 67, Iss. 1, pp. 145-158
Open Access | Times Cited: 386
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
Chiadi E. Ndumele, Janani Rangaswami, Sheryl L. Chow, et al.
Circulation (2023) Vol. 148, Iss. 20, pp. 1606-1635
Open Access | Times Cited: 384
Plasma protein patterns as comprehensive indicators of health
Stephen A. Williams, Mika Kivimäki, Claudia Langenberg, et al.
Nature Medicine (2019) Vol. 25, Iss. 12, pp. 1851-1857
Open Access | Times Cited: 377
Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
Giovanni Targher, Herbert Tilg, Christopher D. Byrne
˜The œLancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 7, pp. 578-588
Open Access | Times Cited: 371
Impaired Adipogenesis and Dysfunctional Adipose Tissue in Human Hypertrophic Obesity
Ann Hammarstedt, Silvia Gogg, Shahram Hedjazifar, et al.
Physiological Reviews (2018) Vol. 98, Iss. 4, pp. 1911-1941
Open Access | Times Cited: 361
Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars
Panu K. Luukkonen, Sanja Sädevirta, You Zhou, et al.
Diabetes Care (2018) Vol. 41, Iss. 8, pp. 1732-1739
Open Access | Times Cited: 356
Page 1 - Next Page

Scroll to top